Latest News

• Zanidatamab approved for NHS use by NICE
• NICE publishes draft recommendation for larotrectinib
• Molecular profiling for patients with Cholangiocarcinoma in Scotland
• The Rare Cancers Act is now law
• Cholangiocarcinoma Awareness Month – February 2026
• The UK Government has published their National Cancer Plan for England
• NICE publishes draft recommendation for zanidatamab
• Biliary tract cancer patient and caregiver experiences survey 2025 report
• A message from Helen Morement, DSc (hc), AMMF’s CEO
• The Scottish Government approve molecular profiling programme for cholangiocarcinoma patients
• AMMF is Shaping the Future for Cholangiocarcinoma in Westminster
• In Memory of James Hastings
• Ivosidenib approved for reimbursement in Ireland
• Scottish Parliament debates cholangiocarcinoma awareness
• Scottish Parliament to debate cholangiocarcinoma awareness
• Jess’s Rule: New Guidance for GPs in England
• Durvalumab approved for reimbursement in Ireland
• CCA-UK – Annual Meeting
• AMMF unites with cancer charities to urge the government to fully fund the National Cancer Plan
• 10 Year Health Plan for England